Isabel Graupera

Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections.

Pose E, Coll M, Martínez-Sánchez C, Zeng Z, Surewaard BGJ, Català C, Velasco-de Andrés M, Lozano JJ, Ariño S, Fuster D, Niñerola-Bazán A, Graupera I, Muñoz É, Lozano F, Sancho-Bru P, Kubes P, Ginès P.

Hepatology. 2021 Jul. 74(1):296-311. PMID: 33219516

Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population-based study.

Pose E, Pera G, Torán P, Gratacós-Ginès J, Avitabile E, Expósito C, Díaz A, Graupera I, Rubio AB, Ginès P, Fabrellas N, Caballeria L.

Liver Int. 2021 07. 41(7):1556-1564. PMID: 33595176

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.

Blaya D, Pose E, Coll M, Lozano JJ, Graupera I, Schierwagen R, Jansen C, Castro P, Fernandez S, Sidorova J, Vasa-Nicotera M, Solà E, Caballería J, Trebicka J, Ginès P, Sancho-Bru P.

JHEP Rep. 2021 Apr. 3(2):100233. PMID: 33665588

Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis.

Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R.

Gut. 2021 Jan 12. PMID: 33436495

Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).

Mezzano G, Cárdenas A, Aguilar F, Pavesi M, Solé C, Napoleone L, Graupera I, Juanola A, Carol M, Pose E, Fabrellas N, Hernaez R, Martínez J, Saliba F, Arroyo V, Sola E, Gines P.

Dig Liver Dis. 2021 Jun. 53(6):738-745. PMID: 33446445

Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis.

Ferrusquía-Acosta J, Bassegoda O, Turco L, Reverter E, Pellone M, Bianchini M, Pérez-Campuzano V, Ripoll E, García-Criado Á, Graupera I, García-Pagán JC, Schepis F, Senzolo M, Hernández-Gea V.

J Hepatol. 2021 Apr. 74(4):811-818. PMID: 33068638

Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.

Solé C, Guilly S, Da Silva K, Llopis M, Le-Chatelier E, Huelin P, Carol M, Moreira R, Fabrellas N, De Prada G, Napoleone L, Graupera I, Pose E, Juanola A, Borruel N, Berland M, Toapanta D, Casellas F, Guarner F, Doré J, Solà E, Ehrlich SD, Ginès P.

Gastroenterology. 2021 01. 160(1):206-218.e13. PMID: 32941879

Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.

Grønbaek H, Møller HJ, Saliba F, Zeuzem S, Albillos A, Ariza X, Graupera I, Solà E, Amoros A, Pavesi M, Bossen L, Jalan R, Gines P, Arroyo V.

J Gastroenterol Hepatol. 2021 Jan. 36(1):240-248. PMID: 32478437

Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with ß-blockers and ligation.

Ardevol A, Alvarado-Tapias E, Garcia-Guix M, Brujats A, Gonzalez L, Hernández-Gea V, Aracil C, Pavel O, Cuyas B, Graupera I, Colomo A, Poca M, Torras X, Concepción M, Villanueva C.

Dig Liver Dis. 2020 09. 52(9):1017-1025. PMID: 32653417

Short-term hemodynamic effects of ß-blockers influence survival of patients with decompensated cirrhosis.

Alvarado-Tapias E, Ardevol A, Garcia-Guix M, Montañés R, Pavel O, Cuyas B, Graupera I, Brujats A, Vilades D, Colomo A, Poca M, Torras X, Guarner C, Concepción M, Aracil C, Torres F, Villanueva C.

J Hepatol. 2020 10. 73(4):829-841. PMID: 32298768